2024 Annual Report of Metabolism and Target Organ Damage
In 2024, Metabolism and Target Organ Damage (M&TOD) has witnessed a remarkable year of growth and success. This success would not have been possible without the invaluable support of our Editor-in-Chief, Prof. Amedeo Lonardo; Honorary Editors, Prof. Christopher D. Byrne and Prof. Giovanni Targher, and all members of the Editorial Board. We extend our heartfelt gratitude to all Editorial Board members, authors, readers, and reviewers, whose dedication and hard work have been pivotal in driving the journal's progress.
The Editorial Office is proud to present the journal's key achievements in 2024, which include:
Highlights:
- Submissions and Publications: Received 144 submissions in 2024, an impressive 128.6% increase from 2023 (63 submissions); published 49 papers, a 113.0% increase over the previous year (23 publications).
- Special Issues: Launched 15 Special Issues led by experts from various countries.
- Citations: Articles were cited 169 times in 2024, representing a remarkable 77.9% rise from 2023 (95 citations).
- Editorial Board: Welcomed 34 new Editorial Board members and 44 new Young Editorial Board members in 2024, expanding the Editorial Board to 72 members from 16 countries/regions, with 90% having an H-index greater than 30.
- Webinars: Hosted 2 webinars, attracting nearly 40,000 online viewers.
- Interviews: Conducted face-to-face interviews with 12 distinguished experts.
- Editorial Meetings: Held 3 online Editorial Board meetings.
- Databases: Achieved a CiteScore of 3.0, indexed in ESCI, and will receive its first Impact Factor in June 2025.
1.Submissions and Publications
1657.png "1718073929741638.jpg")
Figure 2. Submissions and Publications from 2021 to 2024
In 2024, M&TOD received 144 submissions, with 49 papers already published (Figure 2). Both submissions and publications have increased year by year.
1866.png "1718073929741638.jpg")
Figure 3. Rejection Rate from 2021 to 2024
The rising rejection rates reflect M&TOD's ongoing commitment to maintaining high-quality scholarly publishing.
2023.png "1718073929741638.jpg")
Figure 4. Article Types of All Publications
The range of article types has broadened, with review articles accounting for 52% and original research articles comprising 14%.
2199.png "1718073929741638.jpg")
Figure 5. Country Distribution of Authors
As of 2024, M&TOD has 433 authors from 28 countries/regions, with Italy, the United States, and China leading the list.
2.Special Issues
In 2024, we launched 15 Special Issues, featuring 33 distinguished Guest Editors. These Special Issues cover a wide range of topics, and we welcome all researchers to contribute to areas aligned with their research interests.
Table 1. Special Issues released in 2024
| Cover | Topic | Guest Editors | Link |
|---|---|---|---|
2680.png "1718073929741638.jpg") | Hypertension and Metabolic Disorders: Pathophysiology, Clinical Management, and Novel Therapeutic Approaches | Prof. Xingjiang Xiong Prof. Pengqian Wang Prof. Wei Liu Dr. Lian Duan | https://www.oaepublish.com/specials/mtod.2121 |
2970.png "1718073929741638.jpg") | Mitochondrial Bioenergetics in Metabolic Diseases | Dr. Ayman Moawad Mahmoud Dr. Chen Li | https://www.oaepublish.com/specials/mtod.2086 |
3168.png "1718073929741638.jpg") | Diabetic Foot Ulcers: Innovative Management and Treatment | Dr. Thomas E. Serena | https://www.oaepublish.com/specials/mtod.2128 |
3359.png "1718073929741638.jpg") | Metabolic and Alcohol-Related Dual Liver Injury: Exploring MetALD | Prof. Vincent Wai Sun Wong Dr. Luis Antonio Diaz | https://www.oaepublish.com/specials/mtod.2070 |
3587.png "1718073929741638.jpg") | Intestinal Microbiome, Metabolism, and Metabolic Syndrome | Prof. Zheng Ruan | https://www.oaepublish.com/specials/mtod.2012 |
 | Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches | Prof. Sonia Michael Najjar | https://www.oaepublish.com/specials/mtod.2034 |
4083.png "1718073929741638.jpg") | Cardiac Metabolism and Cardiovascular Health: Unveiling the Molecular Nexus | Dr. Stefano Bonapace Prof. Alessandro Mantovani | https://www.oaepublish.com/specials/mtod.1930 |
 | Exploring Exercise-Programed Cardiovascular Metabolism: Mechanisms, Implications, and Clinical Applications | Prof. Xing Zhang Prof. Xinghua Qin | https://www.oaepublish.com/specials/mtod.4319 |
4574.png "1718073929741638.jpg") | Tumor Metabolism: From Basic Research to Clinical Applications | Dr. Chenghao Zhanghuang Dr. Jialin Meng Dr. Zhennan Tao Dr. Jinkui Wang | Closed |
4829.png "1718073929741638.jpg") | Clinical Advances in Bariatric Surgery: Current Trends, Outcomes, and Future Perspectives | Dr. Wah Yang Dr. Sjaak Pouwels | https://www.oaepublish.com/specials/mtod.1982 |
5062.png "1718073929741638.jpg") | The Evolving Nomenclature of the Metabolic Fatty Liver Syndromes: NAFLD/NASH and MAFLD/MASLD | Prof. Amedeo Lonardo | https://www.oaepublish.com/specials/mtod.1887 |
5287.png "1718073929741638.jpg") | Advances in Immunometabolism: Bridging Fundamental Mechanisms and Therapeutic Innovations | Prof. Zhinan Yin Prof. Qian Wang Prof. Ziyu Meng | https://www.oaepublish.com/specials/mtod.2361 |
5475.png "1718073929741638.jpg") | Bile Acids and Gut Microbiota: Bridging Metabolism and Health | Prof. Huiping Zhou Prof. Phillip B. Hylemon Dr. Sayed O. Aseem | https://www.oaepublish.com/specials/mtod.2249 |
5649.png "1718073929741638.jpg") | Interactions of HBV Infection with MASLD Pathobiology | Prof. George Lau | https://www.oaepublish.com/specials/mtod.2171 |
5769.png "1718073929741638.jpg") | Metabolic Mysteries: The Role of Copper Dysregulation in Liver Disease | Prof. Ralf Weiskirchen Prof. Wolfgang Stremmel | https://www.oaepublish.com/specials/mtod.2273 |
3. Citations
In 2024, Articles in M&TOD were cited 169 times, an increase of 77.9% compared to 95 citations in 2023.
6067.png "1718073929741638.jpg")
Figure 6. Citations from 2021 to 2024 (Google Scholar)
Table 2. Top 10 most-read articles in 2024
| Title | Corresponding author(s) | Link | Views |
|---|---|---|---|
| Obesity and diabetes in heart disease in women | Puja K. Mehta | https://www.oaepublish.com/articles/mtod.2023.30 | 1840 |
| Diabetes mellitus and heart disease | Ralf Weiskirchen Preethi Chandrasekaran | https://www.oaepublish.com/articles/mtod.2024.15 | 1747 |
| Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm | Ahmed M. Ali | https://www.oaepublish.com/articles/mtod.2023.33 | 1548 |
| MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome? | Christopher D. Byrne | https://www.oaepublish.com/articles/mtod.2024.06 | 1334 |
| Cancer drugs and diabetic retinopathy: a dangerous, underestimated association | Agostino Milluzzo | https://www.oaepublish.com/articles/mtod.2023.43 | 979 |
| Hypogonadism: cardiometabolism and gonadal function in men | David Cahill | https://www.oaepublish.com/articles/mtod.2023.58 | 828 |
| Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease | Reeti Gulati | https://www.oaepublish.com/articles/mtod.2023.45 | 820 |
| Long-term complications of significant weight loss: lessons learned from bariatric surgery | Carel W Le Roux | https://www.oaepublish.com/articles/mtod.2023.46 | 791 |
| Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review | Amedeo Lonardo | https://www.oaepublish.com/articles/mtod.2024.07 | 740 |
4.Editorial Board
We are pleased to have welcomed 34 new members to our Editorial Board in 2024, expanding our team to 72 members from 16 countries/regions, with the majority from Italy, USA, and China.
8230.png "1718073929741638.jpg")
Figure 7. Country/Region Distribution of Editorial Board Members
8302.png "1718073929741638.jpg")
Figure 8. H-index Distribution of Editorial Board Members
Among the 72 Editorial Board members, 90% have an H-index greater than 30, and 40% exceed an H-index of 50. These figures underscore the strength and expertise of our editorial team.
8545.png "1718073929741638.jpg")
Figure 9. 34 New Editorial Board Members
In addition, 44 new Young Editorial Board members joined M&TOD in 2024, adding further diversity and fresh perspectives to our editorial team.
8732.png "1718073929741638.jpg")
Figure 10. 44 New Editorial Board Members
5.Webinars:
In 2024, we hosted two successful webinars, attracting nearly 40,000 online viewers.
1)Topic: Steatotic Liver Disease: Beyond Nomenclature to Understanding
- Chairs: Dr. Naim Alkhouri and Dr. Luis Antonio Diaz
- Moderator: Dr. Vincent Wai Sun Wong
- Speakers: Dr. Mary Rinella, Dr. Jeffrey V. Lazarus, Dr. Juan Pablo Arab
Online Viewership: Over15,000 online viewers
9149.png "1718073929741638.jpg")
2)Topic: Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches
- Chair: Prof. Ralf Weiskirchen
- Scientific Secretariat: Prof. Amedeo Lonardo
- Moderator: Dr. Gyorgy Baffy
- Speakers: Prof. Wolfgang Stremmel, Dr. Mohamad Jamalinia, Prof. Alessandro Mantovani, Dr. Shelley Keating, Asst. Prof. Thomas Jensen
- Online Viewership: Over25,000 online viewers
9579.png "1718073929741638.jpg")
6.Interviews:
In 2024, we had the privilege of interviewing 12 esteemed experts in the field, including:
| Prof. George Lau | Prof. Robert J. Wong |
| Prof. Huiping Zhou | Prof. Matias A Avila |
| Prof. Takhar Kasumov | Prof. Lemin Zheng |
| Prof. Kezhong Zhang | Prof. Ralf Weiskirchen |
| Prof. Jacob A. George | Prof. David R. Sinacore |
We are deeply grateful for their time and invaluable insights. These interviews facilitated direct communication with these experts, providing a platform to discuss their constructive suggestions for the journal’s development. Additionally, these conversations have helped foster ongoing engagement between M&TOD and the broader academic community.
10245.png "1718073929741638.jpg")
10247.png "1718073929741638.jpg")
10250.png "1718073929741638.jpg")
10252.png "1718073929741638.jpg")
10255.png "1718073929741638.jpg")
10257.png "1718073929741638.jpg")
10260.png "1718073929741638.jpg")
10262.png "1718073929741638.jpg")
10265.png "1718073929741638.jpg")
10267.png "1718073929741638.jpg")
10270.png "1718073929741638.jpg")
10272.png "1718073929741638.jpg")
7.Editorial Board Meetings
In 2024, we held three Editorial Board meetings, where Prof. Amedeo Lonardo and board members discussed the journal's future directions, and received constructive feedback to guide the future development of M&TOD.
8.Databases
M&TOD achieved a CiteScore of 3.0 in 2024 and was successfully indexed in ESCI, and is on track to receive its first Impact Factor in June 2025.
10674.png "1718073929741638.jpg")
10675.png "1718073929741638.jpg")
2024 has been a bumper year for M&TOD, marked by substantial growth in submissions, publications, and citations. Our expanded Editorial Board, the success of webinars and interviews, and the launch of numerous Special Issues demonstrate the continued commitment to advancing research in metabolism and target organ damage. We sincerely thank all contributors and look forward to further progress in 2025.
Editor: Alani Luo
Language Editor: Catherine Yang
Production Editor:
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage
